BMPR2 and pulmonary arterial hypertension: In our previous study, the overall survival difference of BMPR2 mutation carriers compared with non-carriers was more obvious in males than females, due to the more complicated pathogenesis of PAH in female patients, where the impact of BMPR2 mutation was greatly modified by other unknown factors (35).